Assignee
CRESCENDO BIOLOGICS LTD
GB·17 granted patents·12 pending applications·56 citations·filing 2012–2024
Top patents by PatentIndex Score
29 records- 0194US9439405B2Mouse λ light chain locusCRESCENDO BIOLOGICS LTD·Filed 2012·Granted Sep 13, 2016·23 cites·8 claims
- 0291US11236174B2Therapeutic moleculesCRESCENDO BIOLOGICS LTD·Filed 2017·Granted Feb 1, 2022·7 cites·10 claims
- 0389US10975161B2Molecules that bind prostate specific membrane antigen (PSMA)CRESCENDO BIOLOGICS LTD·Filed 2017·Granted Apr 13, 2021·9 cites·17 claims
- 0488US11667705B2IL-17A binding proteinsCRESCENDO BIOLOGICS LTD·Filed 2020·Granted Jun 6, 2023·2 cites·7 claims
- 0587US11312771B2Single-domain antibodies to programmed cell death 1 protein (PD-1), encoding nucleic acids and methods of using sameCRESCENDO BIOLOGICS LTD·Filed 2018·Granted Apr 26, 2022·4 cites·16 claims
- 0686US10194645B2Mouse λ light chain locusCRESCENDO BIOLOGICS LTD·Filed 2016·Granted Feb 5, 2019·3 cites·7 claims
- 0784US11591398B2Single domain antibodies to programmed cell death protein 1 (PD-1)CRESCENDO BIOLOGICS LTD·Filed 2018·Granted Feb 28, 2023·3 cites·17 claims
- 0884US10654924B2IL-17A binding proteinsCRESCENDO BIOLOGICS LTD·Filed 2016·Granted May 19, 2020·2 cites·17 claims
- 0981US11814429B2Single domain antibodies to programmed cell death (PD-1)CRESCENDO BIOLOGICS LTD·Filed 2018·Granted Nov 14, 2023·2 cites·10 claims
- 1079US2023406954A1Therapeutic moleculesCRESCENDO BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 1178US2024199731A1Il-17a binding proteinsCRESCENDO BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 1277US10947308B2Composition for treatment of disordersCRESCENDO BIOLOGICS LTD·Filed 2017·Granted Mar 16, 2021·1 cites·18 claims
- 1377US2023357405A1Single domain antibodies to programmed cell death protein 1 (pd-1)CRESCENDO BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 1473US11746158B2Therapeutic moleculesCRESCENDO BIOLOGICS LTD·Filed 2021·Granted Sep 5, 2023·0 cites·12 claims
- 1573US2022306744A1Single Domain Antibodies to Programmed Cell Death (PD-1)CRESCENDO BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 1666US2024350651A1Therapeutic molecules that bind to lag3 and pd1CRESCENDO BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1765US2023133028A1Transgenic miceCRESCENDO BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 1864US12134643B2Compositions for treatment of disordersCRESCENDO BIOLOGICS LTD·Filed 2021·Granted Nov 5, 2024·0 cites·20 claims
- 1956US11951172B2Therapeutic molecules that bind to LAG3 and PD1CRESCENDO BIOLOGICS LTD·Filed 2019·Granted Apr 9, 2024·0 cites·24 claims
- 2051US2022220215A1Binding moleculesCRESCENDO BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 2151US2022227850A1Binding moleculesCRESCENDO BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 2250US2021340233A1Single domain antibodies that bind human serum albuminCRESCENDO BIOLOGICS LTD·Filed 2019·Application pending·0 cites
- 2348US11866510B2Chimeric antigen receptor with single domain antibodyCRESCENDO BIOLOGICS LTD·Filed 2017·Granted Jan 9, 2024·0 cites·13 claims
- 2448US2017306319A1Vh scaffoldCRESCENDO BIOLOGICS LTD·Filed 2014·Application pending·0 cites
- 2547US2017306039A1Human vh domain scaffoldsCRESCENDO BIOLOGICS LTD·Filed 2014·Application pending·0 cites
- 2643US2018215829A1Anti-il-17ra immunoglobulin single heavy variable domain antibodiesCRESCENDO BIOLOGICS LTD·Filed 2016·Application pending·0 cites
- 2737US11401342B2Therapeutic molecules binding PSMACRESCENDO BIOLOGICS LTD·Filed 2018·Granted Aug 2, 2022·0 cites·22 claims
- 2836US12077595B2Single domain antibodies that bind to CD137CRESCENDO BIOLOGICS LTD·Filed 2018·Granted Sep 3, 2024·0 cites·15 claims
- 2935US10400030B2Methods for producing optimised therapeutic moleculesCRESCENDO BIOLOGICS LTD·Filed 2016·Granted Sep 3, 2019·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when CRESCENDO BIOLOGICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →